FDA Changes Course on Plasma Treatment

Chief acknowledges overstating treatment effect.

The Food and Drug Administration announced that it had gone too far in promoting the treatment effects of convalescent plasma in fighting against COVID-19 after feedback from medical professionals. FDA Commissioner Stephen Hahn had initially stated that 35 out of 100 people would survive COVID-19 if they received the transfusion – a claim supported by President Trump.

Commissioner Hahn said, “I have been criticized for remarks I made Sunday night about the benefits of convalescent plasma. The criticism is entirely justified. What I should have said better is that the data show a relative risk reduction, not an absolute risk reduction.” The 35% figure cannot be substantiated due to no control group being used in the studying of the treatment. 

As the Lord Leads, Pray with Us…

  • For God to lead the president’s administration to find the best cures for COVID-19.
  • That the FDA would approve proven cures for COVID-19.
  • For Commissioner Hahn to be given wisdom from above on how to fight the pandemic.

Sources: AP, CNN, NPR


Back to top